$0.000001
At close: Dec 11, 12:33 PM EDT
$0.000001
0.000.00%
After Hours: Mar 21, 4:21 PM EDT
Comments
Loading...
MedGen Analyst Ratings and Price Targets | OTC:MDIN | Benzinga
MedGen Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for MedGen Corp from these most-recent analyst ratings.
Analyst Ratings for MedGen
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for MedGen (MDIN) stock?
There is no price target for MedGen
What is the most recent analyst rating for MedGen (MDIN)?
There is no analyst for MedGen
When was the last upgrade for MedGen (MDIN)?
There is no last upgrade for MedGen
When was the last downgrade for MedGen (MDIN)?
There is no last downgrade for MedGen.
When is the next analyst rating going to be posted or updated for MedGen (MDIN)?
There is no next analyst rating for MedGen.
Is the Analyst Rating MedGen (MDIN) correct?
There is no next analyst rating for MedGen.
Browse analyst ratings and price targets on all stocks.
